UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012450 |
|---|---|
| Receipt number | R000014551 |
| Scientific Title | Phase II study of continuation maintenance by use of nab-Paclitaxel and Bevacizumab after induction chemotherapy of Carboplatin and nab-Paclitaxel pulse bevacizumab in chemotherapy-naïve patients with Stage IIIB / IV non-squamous and non-small cell lung cancer. |
| Date of disclosure of the study information | 2013/12/02 |
| Last modified on | 2018/06/10 11:26:06 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/12/01 14:40:28 | ||
| 2 | Update | 2015/06/06 08:37:53 | Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2015/12/01 18:19:55 | Last follow-up date |
|
| 4 | Update | 2016/09/02 16:13:24 | Name of primary person or sponsor Organization |
|
| 5 | Update | 2018/06/10 11:26:06 | Recruitment status Last follow-up date Results Results |
